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At a low MOI (r0.01), cytomegalovirus-associated programmed cell death terminates productive
infection via a pathway triggered by the mitochondrial serine protease HtrA2/Omi. This infected cell
death is associated with late phase replication events naturally suppressed by the viral mitochondrial
inhibitor of apoptosis (vMIA). Here, higher MOI (ranging from 0.1–3.0) triggers cell death earlier during
infection independent of viral DNA synthesis. Thus, MOI-dependent activating signals early, at high
MOI, or late, at low MOI, during replication promote serine protease-dependent death that is
suppressed by vMIA. Treatment with an antioxidant targeting reactive oxygen species (ROS) or the
serine protease inhibitor N-alpha-p-tosyl-L-lysine chloromethyl ketone (TLCK) delays cell death, and
the combination has an additive impact. These studies identify serine proteases and ROS as important
factors triggering programmed cell death induced by vMIA-deﬁcient virus, and show that this death
pathway occurs earlier and reduces viral yields as the MOI is increased.
& 2012 Elsevier Inc. All rights reserved.Introduction
Programmed cell death is an evolutionarily ancient response
to intracellular pathogens that is triggered by cell-intrinsic and
cell-extrinsic signaling and follows caspase-dependent as well as
caspase-independent pathways (Barber, 2001; Lamkanﬁ and
Dixit, 2010; Mocarski et al., 2011). Human cytomegalovirus
(CMV) (HCMV) and murine CMV (MCMV) inhibit caspase-
dependent cell death (apoptosis) as well as other death pathways
that have come to light through the study of virus-encoded cell
death suppressors, that include some of the only evolutionarily
conserved host modulatory functions retained by these two
biologically similar but genetically divergent pathogens (Brune,
2011; McCormick, 2008; Mocarski et al., 2011). For some CMV cell
death suppressors, mutant viruses trigger well characterized
pathways. Thus, apoptosis triggered by activation of caspase-8
following infection is suppressed by the viral inhibitor of caspase-
8 activation (vICA), encoded by HCMV UL36 or MCMVM36 (Cicin-
Sain et al., 2008; McCormick et al., 2010; Menard et al., 2003;
Skaletskaya et al., 2001). A novel programmed death pathway,
referred to as cytomegalovirus-associated programmed cell death
(cmvPCD) emerged from studies of vMIA encoded by HCMV
UL37x1 (McCormick et al., 2008). This programmed cell death
pathway is sensitive to serine protease inhibitor TLCK as wellll rights reserved.
mune, Mountain View, CA,
.L. McCormick).as the HtrA2/Omi inhibitor USF101 and proceeds independent of
caspase activation. Although this death pathway takes place
during infection with HCMV strain TownevarATCC (Towne-BAC)
(McCormick et al., 2005, 2008), UL37x1 mutant viruses made from
variants of strain AD169 have exhibited variable cell death patterns
and replication defects that suggest the pathway is sensitive to
differences in host cells and viral genetic background (Kaarbo et al.,
2011; Reboredo et al., 2004; Sharon-Friling et al., 2006). In this report,
we have used the inhibitor, TLCK, together with viral mutants to
begin to understand how genetic differences and infection conditions
impact cmvPCD and to dissect whether this pathway has the
potential to impair viral replication as a component of host defense,
an important role of other programmed cell death pathways such as
apoptosis (Lamkanﬁ and Dixit, 2010) and virus-induced necrosis
(Upton et al., 2010, 2012).
At low MOIs (o0.1), cmvPCD is triggered late in infection and
proceeds through a cellular process of fragmentation involving
both the nucleus and cytoplasm (McCormick et al., 2008). This
work revealed that infected human ﬁbroblasts (HFs) undergo
TLCK-sensitive cmvPCD independent of vMIA expression in a
pattern that nonetheless demonstrated a natural role for this cell
death suppressor in delaying the execution of cmvPCD. vMIA-
deﬁcient Towne-BAC virus (DUL37x1) was shown to undergo
TLCK-sensitive cmvPCD approximately three days earlier than
Towne-BAC at low MOI (o0.01) and vMIA-expressing HFs
reversed this early pattern of death (McCormick et al., 2008).
Thus, DUL37x1-induced cmvPCD begins on day 3 postinfection,
with a frequency of r10%, and increases over 2 to 3 days,
reaching 100% by day 5 to 6. In contrast, cmvPCD induced by
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through day 10. Despite the earlier appearance of cell death,
DUL37x1 virus produces similar yields of progeny and spreads
cell-to-cell at a similar rate compared to Towne-BAC . cmvPCD is
triggered by increasing levels of HtrA2/Omi (McCormick et al.,
2008), a mitochondrial serine protease that contributes to both
caspase-dependent and caspase-independent pathways, classi-
cally dependent on release from mitochondria (Vande Walle
et al., 2008). Transient elevation of HtrA2/Omi levels within
mitochondria promotes and overexpression of vMIA delays cmvPCD,
suggesting a mechanism where mitochondrial localized vMIA main-
tains control over this pathway (McCormick et al., 2008). To address
the trigger(s) that activate serine protease-dependent death during
CMV infection, we evaluated the inﬂuence of MOI on timing of cell
death. Importantly, these studies revealed MOI-dependent activation
of cmvPCD more severely limits viral yields, emphasizing the role of
cmvPCD as a host defense pathway. Input viral particles were
insufﬁcient to induce cmvPCD, however, a MOI-dependent timing
of cell death was observed. At lower MOIs, initiation of cmvPCD was
dependent on late replication events; whereas, viral immediate early
or early gene products triggered cell death under higher MOI
conditions. In addition to serine proteases, higher MOI revealed
ROS-dependent control of cmvPCD, consistent with a role of HtrA2/
Omi in regulation of oxidative stress (Krick et al., 2008). Thus, here we
report that TLCK, a serine protease inhibitor, or BHA, an antioxidant
can inhibit premature cmvPCD initiated by elevated multiplicity in
the absence of vMIA.Results
Dependence of intrinsic cell death controlled by vMIA on cell source
and viral strain
To directly evaluate the potential contribution of cell source to
differences in cell death induced by UL37x1 mutant viruses, we
determined infectivity of Towne-BAC-derived DUL37x1 (McCormick
et al., 2005) or AD169-BAC-derived RVHB5delUL37x1 (Reboredo
et al., 2004) following transfection. Consistent with previous reports,
DUL37x1 virus (McCormick et al., 2005) was recovered from HFs but
RVHB5delUL37x1 virus (Reboredo et al., 2004) was not (data not
shown). DUL37x1 and RVHB5delUL37x1 viruses replicated on vMIA-
HFs, however, plaque size and recovered titers indicated RVHB5de-
lUL37x1 was more defective than DUL37x1 even in vMIA-
complementing cells (data not shown). Overall, these results highlight
genetic differences underlie replication properties of RVHB5de-
lUL37x1 and DUL37x1. Cell source or culture conditions alone do
not control differences in the replication properties of these viruses.
Furthermore, the inability to completely complement RVHB5de-
lUL37x1 replication in vMIA-HFs suggested that adventitious muta-
tions may have accompanied the mutation of UL37x1 in this virus
and contributed to decreased replication potential.
MOI-dependent intrinsic cell death pathways controlled by vMIA are
induced at different stages of replication
To investigate the contribution of the input dose of virus to
patterns of cell death and replication, vMIA-deﬁcient DUL37x1
and Towne-BAC infections were carried out at MOIs of 1.0, 0.1 and
0.01 (Fig. 1). As previously (McCormick et al., 2008), we relied on
GFP ﬂuorescence produced from these viruses as an initial,
indirect indicator of viral yields. At MOI 1.0, ﬂuorescence of
DUL37x1-infected cultures was similar to Towne-BAC cultures
early in infection (r54 hpi), but was decreased relative to
Towne-BAC at all late times evaluated (72–162 hpi) (Fig. 1A–G).
In contrast, at MOI 0.1, GFP ﬂuorescence of DUL37x1-infectedcultures remained equivalent to Towne-BAC through 90 hpi,
decreasing only after 108 hpi (Fig. 1H–N ). At the lowest MOI
(0.01), the ﬂuorescence of DUL37x1-infected cells was weaker
than Towne-BAC at late times (144–162 hpi) (Fig. 1O–R ). At this
low MOI, equivalent foci were obvious by 120 hpi, consistent with
our earlier characterization of this mutant virus that indicated
differences between DUL37x1 and Towne-BAC emerge only after
initial cell-to-cell spread (McCormick et al., 2005; McCormick
et al., 2008). Overall, this evaluation revealed a multiplicity-
dependent difference in ﬂuorescence between DUL37x1 and the
parental Towne-BAC, but, importantly, showed that the beneﬁt of
vMIA function(s) depends on the MOI employed.
To extend this analysis and evaluate differences in replication,
yields from DUL37x1 and Towne-BAC virus were determined at
daily intervals after infection at an MOI of 1 or 0.001 (Fig. 2A). At
the higher MOI, DUL37x1 yields stopped rising after 72 hpi, in
striking contrast to the increase between 72 and 120 hpi with
Towne-BAC . Mean titer values differed by 6- and 19-fold by 96
and 120 hpi, respectively, reaching statistical signiﬁcance on both
days. In comparison, mean titer values at low MOI differed by
only 2.3 and 2.5 fold, respectively, at these same times, a value
that, although statistically different at 96 hpi, was reduced in
comparison to yields that followed infection at high MOI.
Recently, impaired mitochondrial biogenesis in AD169-derived
DUL37x1 has been correlated with a two-fold difference in viral
titers, the expected result of the UL37x1-deﬁciency (Kaarbo et al.,
2011). Here, emergence of GFPþ foci and cell death by 96–120
hpi (Fig. 1 and data not shown), indicated the two-fold difference
in viral yield at low multiplicity as well as the larger differences at
higher multiplicity, would likely reﬂect the impact of multiple
factors. Thus, we focused the remaining studies on cell death as
well as viral replication.
To conﬁrm the direct impact of vMIA function on replication at
high MOI, HFs and HFs constitutively expressing vMIA
(McCormick et al., 2005) were infected with DUL37x1 or
Towne-BAC at MOI 3.0 (Fig. 2B). DUL37x1 titers at 120 hpi were
lower compared to Towne-BAC (Z50 fold) (Fig. 2B), similar to
differences at MOI 1.0 (Fig. 2A). HFs transduced with vMIA
complemented viral yields to Towne-BAC levels (Fig. 2B), demon-
strating a signiﬁcant role for vMIA in viral replication. From
ﬂuorescence intensity patterns, emergence of cell-to-cell GFPþ
cells or foci (Fig. 1) and viral yields (Fig. 2A–B), it appeared that
high MOI infection is associated with the induction of cell death
at early times in a manner that is different from low MOI.
vMIA has been associated with suppressing cell death and as
well, promoting endoplasmic reticulum calcium release and
mitochondrial biogenesis during infection (Kaarbo et al., 2011;
McCormick et al., 2008; Sharon-Friling et al., 2006). At low
MOI, Towne-BAC-derived DUL37x1 replication induces and vMIA
suppresses a late phase event that triggers cell death (McCormick
et al., 2008). Because higher MOI infection altered the timing
and magnitude of GFP ﬂuorescence and viral yield earlier dur-
ing infection (Figs. 1 and 2A–B ), we re-evaluated timing and
replication-phase speciﬁc contributions to premature cell death
(Fig. 2C–F ). By Trypan Blue exclusion, approximately 50% of the
total cells in DUL37x1-infected cultures (MOI of 1.0) remained
viable 72–96 hpi, decreasing to less than 20% by 120 hpi. In
comparison, Towne-BAC infected cultures remained fully viable
through 120 hpi (data not shown). To determine whether the
decreased viability reﬂected a loss of infected cells, viral immedi-
ate early (IE) nuclear antigen positive (IEþ) cells were scored
daily after infection (MOI of 1.0; Fig. 2D). IEþ cell numbers in
DUL37x1-infected cultures were highest at 24 hpi and decreased
from 48 through 72 hpi (74% and 34%, respectively relative to
24 hpi), whereas IEþ cell numbers in Towne-BAC-infected cul-
tures remained constant 24-72 hpi in Towne-BAC cultures. In
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Fig. 1. MOI-dependent impact on GFP ﬂuorescence patterns of DUL37x1 and Towne-BAC viruses. Fluorescence micrographs and mean ﬂuorescence intensities obtained
from HF cells with GFP-expressing DUL37x1 or parental Towne-BAC viruses at an MOI of 1.0 (panels A–G), 0.1 (panels H–N), or 0.01 (panels O–U). Live cell images were
collected by equivalent exposure times to illustrate differences in GFPþ ﬂuorescence intensities, cell number, and cell-to-cell spread (original magniﬁcation 40X). Mean
ﬂuorescence intensity recorded by IncuCyte FLR imaging system from three independent wells infected with Towne-BAC (open symbols) or DUL37x1 (ﬁlled symbols) and
graphed with standard deviation.
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infected cell death contributes to lower viral yields.
Next, we compared the impact of the viral DNA synthesis
inhibitor phosphonoformate (PFA), added from 1 hpi through 72,
96 or 120 hpi, on infection (Fig. 2E). Given that GFP ﬂuorescence is
reduced during PFA treatment (McCormick et al., 2008), infection
was scored by immunoﬂuorescent detection of IE antigen (IEþ)
at 24, 72, 96 and 120 hpi (Fig. 2E). Such treatment at low
MOI prevents cell death (McCormick et al., 2008). In contrast,
IEþ cell number declined dramatically at higher MOI, falling to
o10% viability by 120 hpi in the presence or absence of PFA.
Importantly, PFA blocked viral DNA replication independent of
vMIA expression or MOI (data not shown). Overall, these data
revealed that higher MOI DUL37x1-induced cell death was
triggered by early events preceding viral DNA synthesis, whereas
low input doses resulted in death triggered via late events that
follow DNA replication (McCormick et al., 2008).
Multiplicity-dependent replication (Figs. 1–2A) and a shift in
initiation of cell death from late phase to early phase (Fig. 2E) suggest
a relationship between particle dose and the requirement for vMIA
function. Although the particle-to-PFU ratio of stock preparations
used here were not assessed directly, HCMV strain Towne prepara-
tions have a reported particle-to-PFU ratio of approximately 100
(Stinski et al., 1979) consistent with observations here of decreased
requirement for vMIA at multiplicitiesr1.0. To determine whetherviral particles contributed to DUL37x1-induced cell death, UV-
inactivated viral particles were added to lowMOI DUL37x1 infections
to mimic highMOI conditions (Fig. 2F). Cell death was evaluated early
(at 72 hpi) when r10% of infected cells have died under low MOI
conditions (McCormick et al., 2008) and Z50% of infected cells have
died at an MOI of 1 (Fig. 2C–D), thereby increasing the sensitivity of
the assay. The addition of UV-inactivated UL37x1 or Towne-BAC
particles made little impact on the DUL37x1-induced cell death
(Fig. 2F). As a measure of their biological activity, UV-inactivated
particles were shown to increase levels of GFP ﬂuorescence of
DUL37x1-infected cells, but neither produced GFPþ signal or repli-
cating virus when added to monolayers directly (data not shown).
Thus, DUL37x1-induced cell death appears to be triggered by entry
and early functions of replication-competent virus and not simply by
the exposure to virus particles. Overall, these data indicate that
infection at higher viral doses is accompanied by earlier cell death,
in line with the observed replication differences between mutant and
parental viruses.
Serine proteases and ROS promote premature cmvPCD
of vMIA-deﬁcient virus
In order to determine whether HtrA2/Omi triggers a serine
protease-dependent cmvPCD pathway at high MOI as occurs at
low MOI (McCormick et al., 2008), the inhibitor TLCK was added
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Fig. 2. Impact of MOI on DUL37x1 virus replication and cell death patterns. (A) Viral yields (titers, determined by plaque assay) of DUL37x1 (square symbols) or Towne-
BAC (round symbols) after infection of HFs at MOIs of 1.0 (ﬁlled symbols) or 0.001 (open symbols). For MOI 1, 120 hpi, p¼0.0019. For MOI 0.001, 120 hpi, p¼0.4044. (B)
Mean viral yield at 120 hpi of HF or vMIA-HF cell cultures with DUL37x1 (gray bars) or Towne (open bars) (MOI 3.0). (C) Percentage (%) of Trypan Blue negative cells (an
indicator of viability) remaining in DUL37x1-infected cell cultures relative to Towne-BAC infected-cultures (MOI of 1.0). (D) Percentage (%) of IEþ cells (an indicator of
infection) in DUL37x1 (gray bars) or Towne-BAC (open bars) infected cultures relative to total IEþ cells at 24 hpi (MOI of 1.0). (E) Percentage (%) of IEþ cells remaining in
PFA-treated DUL37x1-infected cultures relative to 24 hpi (depicted as 100%) following infection at an MOI of 0.001 (hatched square) or 1.0 (ﬁlled square). PFA was added at
300 mg/ml from 1 hpi. (F) Percentage (%) of fragmented GFPþ cells at 72 hpi with DUL37x1 (MOI of 0.001) relative to total GFPþ cells. UV inactivated DUL37x1 or Towne-
BAC were added at the equivalent of an MOI of 3.0 together with DUL37x1. UV treated mock medium or medium without addition served as controls. For all panels, the
mean7standard deviation (SD) represented by error bars is depicted.
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tion was ﬁrst apparent (48 hpi) (Fig. 3A). TLCK treatment dramati-
cally reduced the proportion of cells showing signs of death at
48 hpi. This protective impact correlated directly with the drug
concentration, and, importantly, cell fragmentation was reduced
byZ85% at the highest drug concentration employed (100 mM).
Thus, the cell death pathway induced by higher viral doses is
dependent on serine proteases, as they have been implicated
following low dose infection. The overall impact of the serine
protease inhibitor, when applied at 24 h, improved, but did not
fully restore, viral yields at 120 hpi (Fig. 3B). We had previously
evaluated HtrA2/Omi localization during low MOI infection
(McCormick et al., 2008) that may dictate the initiation of cell
death, but this remains to be explored in the high MOI setting.
Overall, these data indicate that serine proteases control an impor-
tant cell death pathway during infection that has the potential to cut
short replication. Thus, vMIA-dependent suppression of this path-
way may be viewed as crucial to the survival of virus-infected cells.
Because HtrA2/Omi can coordinate with caspases to regulate
apoptosis (Vande Walle et al., 2008), and AD169 UL37x1 mutant
virus can promote a zVAD-sensitive, caspase-dependent cell
death (Reboredo et al., 2004), we evaluated whether caspasesmight be implicated here by using the pan-caspase inhibitor
zVAD-fmk (Fig. 3B). zVAD-fmk failed to prevent cell death at
higher input doses of DUL37x1 (data not shown), consistent with
unchanged viral yields in the absence of TLCK (Fig. 3B). zVAD-fmk
was ineffective regardless of concentrations ranging from
6–50 mM, doses sufﬁcient to prevent cell death induced by
staurosporine (data not shown). In combination, these data
indicate that TLCK is an effective inhibitor of DUL37x1-induced
cell death across a spectrum of virus doses. Based on these and
previous studies (McCormick et al., 2005; McCormick et al., 2008),
cmvPCD proceeds independent of caspases, regardless of the
timing of cell death or inﬂuence of input virus dose. Here, viral
yields indicated zVAD-fmk reduced the effectiveness of TLCK
(Fig. 3B); an unanticipated impact that we believe may indicate
an off-target impact of zVAD-fmk . Overall, these studies impli-
cate a serine protease-dependent death pathway controlled by
vMIA regardless of DUL37x1 infection conditions.
To determine the role of ROS-dependent signaling during
DUL37x1-induced cell death, the antioxidant butylated hydroxya-
nisole (BHA) was used to treat virus-infected cells (Fig. 3C).
Previous evaluations have indicated ROS-signaling regulates NF-
kB- and AP-1-dependent transcription of the major IE promoter
µµ µ
Fig. 3. Serine protease- and ROS-dependent pathways contribute to premature cmvPCD. (A) Percentage (%) of fragmented cells in DUL37x1-infected cultures (MOI of 1.0)
at 48 hpi in the presence of serine protease inhibitor TLCK, applied from 24 hpi, relative to infection in the absence of the inhibitor. (B) Viral yields (titers) from DUL37x1
(gray bars) or Towne–BAC (open bars) infected cells (MOI of 1.0) maintained in the presence of 33 mM TLCK, 25 mM zVAD-fmk, or both, from 24 to 120 hpi. (C) Percentage
(%) of fragmented cells at 72 hpi in DUL37x1 (gray bars) or Towne-BAC (open bars) infected cultures (MOI of 1.0) maintained in presence of BHA added from 6 hpi relative
to untreated, infected cultures. (D) Percentage (%) of ATP detected in DUL37x1 (gray bars) or Towne–BAC (open bars) infected cultures (MOI of 1.0) treated with BHA from
6 to 96 hpi relative to untreated Towne-BAC-infected cultures. (E) Viral yields (titer) of DUL37x1 (D) and Towne-BAC (E) (MOI of 1.0) released into supernatants in cultures
maintained in 63 mM BHA from 8 to 120 hpi. (F) Percentage (%) of IEþ cells remaining at 96 hpi in DUL37x1-infected cultures (MOI of 1.0) treated with PFA or a
combination of PFA and BHA relative to Towne-BAC-infected cultures treated with PFA from 1 hpi. p¼0.0002.
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expression, BHA was added from 6 hpi. Treatment with BHA
reduced the levels of DUL37x1-induced cell death through
72 hpi. This suppression correlated directly with drug concentra-
tions from 31 mM, reducing fragmentation by 35%, to 125 mM,
reducing fragmentation by 85% (Fig. 3C). BHA treatment alone was
not sufﬁcient to maintain infected cell viability through 96 hpi
(Fig. 3D and data not shown) or improve viral yields (Fig. 3E).
However, the drug did not interfere with Towne-BAC infection as
indicated by culture ATP levels and viral titers (Fig. 3D–E ),
suggesting, perhaps, that ROS production overcame the antioxidant
or that an additional stress contributed to cell death 72 to 96 hpi.
To evaluate whether BHA was sufﬁcient to inhibit cell death early
in replication and also, evaluate whether stress activated late in
replication overcame the antioxidant, BHA was added together
with the viral DNA synthesis inhibitor PFA (Fig. 3F). BHA increased
the proportion of IEþ DUL37x1-infected cells from o10% to
425% under these conditions, suggesting that ROS activity in the
early phase of replication contributed to induction of cell death.
Overall, these data reveal that an antioxidant was sufﬁcient to
reduce DUL37x1-induced cell death while TLCK was sufﬁcient to
reduce DUL37x1-induced cell death and increase yield.ROS and serine proteases coordinately control cmvPCD at late times
of infection
TLCK and BHA each inhibited premature cmvPCD by more than
85% at 48–72 hpi when added alone at 24 or 6 h, respectively,
(Figs. 3A, 3C, and data not shown) but lost effect by 96 hpi (Fig. 3D
and data not shown). To determine whether there is a single cell
death pathway inhibited by both drugs or two independent cell
death pathways, we evaluated the time of addition most effective
for each drug in the control of cell death and whether the
antioxidant and protease inhibitor provided a combinatorial
impact that would extend infected cell viability to 96 hpi
(Fig. 4). Initially, we evaluated how late in infection BHA and
TLCK could be added to suppress cell death (Fig. 4A). TLCK and
BHA added at 8 or 24 hpi inhibited premature cell death through
72 hpi, whereas, addition at 48 hpi was less effective. Thus, for
either BHA or TLCK, cell death was reduced by490% when the
inhibitors were added at 24 hpi. In contrast, BHA addition at
48 hpi had no effect and the impact of TLCK, although still
signiﬁcant, was reduced by425%. These results correlated with
time of appearance of cmvPCD by 48–72 hpi (Fig. 2) and are
consistent with both drugs acting on a common pathway. Next,
µ
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Fig. 4. ROS- and serine protease-dependent events coordinate in control of
cmvPCD. (A) Percentage of fragmented cells in DUL37x1-infected cultures relative
to control, mock-treated cultures (MOI of 1.0) maintained in 63 mM BHA, 33 mM
TLCK, or both from 8, 24, or 48 to 72 hpi. Note: medium replacement at 8, 24, or
48 hpi did not alter cell death (data not shown). BHA: po0.0001 (8 and 24 hpi).
TLCK: po0.0001 (8, 24, and 48 hpi). (B) Percentage (%) of IEþ cells remaining in
DUL37x1-infected cultures maintained in BHA, TLCK, or both from 24 to 96 hpi
relative to similarly treated Towne-BAC-infected cultures (MOI of 3.0). Solvent
control (DMSO) was added at 0.01%. 3.7 mM TLCK with 63 mM BHA, p¼0.0237.
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with combinations of drugs varied across multiple concentrations
(Fig. 4B). BHA and TLCK had an additive effect on cell death
at 96 hpi, over multiple drug concentrations consistent with a
common pathway. Whereas TLCK or BHA each had a modest
effect, when combined the drugs decreased cell death by 30% over
untreated control. Thus, inhibiting the pathway controlled by the
antioxidant and the serine protease inhibitor is sufﬁcient to
prevent cell death at 96 hpi. Overall, these data highlight the
coordination of ROS and serine proteases in cmvPCD.Discussion
In this report, we have shown that multiplicity of infec-
tion contributes to premature serine protease-dependent
cmvPCD triggered by HCMV in the absence of vMIA. At low
multiplicitiesr0.01, DUL37x1 replication follows the kinetics
and, nearly, the amplitude of parental virus. At multiplicitiesZ0.1
this virus fails to replicate efﬁciently due to the induction of
premature cell death. The cmvPCD that occurs during Towne-BAC
infection at any multiplicity tested takes place much later such
that cell death does not compromise replication or yields. This
unveils a crucial role for vMIA in counteracting death pathways
that may terminate infection. The pathway promoting cell death
at multiplicitiesZ0.1 is initiated by the combined impact of
particles and early phase events, while the cell death pathway
activated at multiplicitiesr0.01 is initiated by late phase events.
These results suggest that the cellular response(s) that inﬂuencewhether the mutant virus induces cmvPCD may be determined by
different stress or antiviral pathway(s) induced by increased
particle load. Evidence suggests that HCMV infection induces
interferon response pathways that are mirrored by application
of UV-inactivated HCMV particles (Zhu et al., 1997), and we used
UV-inactivated particles here to show that particle load alone, is
insufﬁcient to induce multiplicity-dependent cmvPCD; a result
that leaves open the role(s) of stress or antiviral signaling path-
ways induced by virion components.
Irrespective of multiplicity, cmvPCD is sensitive to the serine
protease inhibitor TLCK, consistent with our previous implication
of serine proteases, including HtrA2/Omi, in cmvPCD. This pro-
tease is also likely to be important for the premature cell death at
elevated multiplicity. In current studies, the pan-caspase inhibitor
zVAD-fmk interfered with replication in the presence of TLCK,
suggesting an off-target effect may mask evidence for the role of
caspases during DUL37x1 infection. As a result, the role of
caspases in cmvPCD remains to be clariﬁed. In addition to serine
protease activity, the current studies revealed ROS as an impor-
tant promoter of cmvPCD, since an antioxidant was sufﬁcient to
inhibit cell death. These data are consistent with accumulating
evidence of increases in ROS during infection (Kaarbo et al., 2011;
Tilton et al., 2011) and activation of HtrA2/Omi in response to
oxidant stress (Krick et al., 2008). Moreover, the effective con-
centration of TLCK required to inhibit cell death was reduced
byZ9 fold in the presence of the antioxidant, suggesting that ROS
levels have a direct impact on levels of serine protease activity.
Thus, these results indicate serine proteases and ROS contributed
toward a single pathway activated at early times.
Mitochondria are the major cellular source of ROS, which is
produced through oxidative phosphorylation. Although redox-
dependent control of NF-kB- and p53-dependent signaling path-
ways may be of beneﬁt to infection, in excess, ROS interfere with
mitochondrial function and as a consequence promote organelle
damage and cell death directly through both apoptotic and
necrotic mechanisms (Hamanaka and Chandel, 2010; Holley
et al., 2010; Krishna et al., 2011; Lamkanﬁ and Dixit, 2010;
Murphy, 2009). In fact, both ROS and the cellular enzymes
important to control ROS levels are reported to rise at late times
of HCMV infection (Kaarbo et al., 2011; Tilton et al., 2011). In
addition, previous studies have indicated the virus encodes
functions that control oxidative stress, such as the b2.7 RNA that
binds mitochondria respiratory complex I (Reeves et al., 2007).
Together with evidence for elevated ROS and viral and cellular
control mechanisms, our results here indicate that vMIA may be
an important component of the viral program to control oxidative
stress. Potential mechanisms for oxidative stress control may
follow interactions with previously identiﬁed cellular proteins
that facilitate vMIA-dependent modulation of mitochondrial
function (Kaarbo et al., 2011; Poncet et al., 2006; Seo et al.,
2011). Thus, the physical interactions of vMIA with viperin, an
interferon-inducible protein, and with the mitochondrial phos-
phate carrier (PiC), a component of the ATP synthasome, have
each been linked to reductions in cellular ATP levels and oxidative
phosphorylation (Poncet et al., 2006; Seo et al., 2011) which may, as a
result, reduce ROS levels. In contrast, infection-related increases in
mitochondrial biogenesis and activity, and thereby ROS levels, have
also been reported to be vMIA-dependent (Kaarbo et al., 2011). In
sum, variable impacts on mitochondrial function prevent a direct
correlation with the current study. The use of AD169-BAC-derived
viruses with different growth properties in previous studies and an
inconsistent use of vMIA-expressing cells to demonstrate that the
phenotype(s) observed result from the absence of vMIA and not some
other inadvertent mutation introduced during mutant construction
highlight potential confounding issues. In our current studies a direct
comparison of RVHB5delUL37x1 (Reboredo et al., 2004) and
A.L. McCormick et al. / Virology 435 (2013) 250–257256DUL37x1(McCormick et al., 2005) revealed such unintended genetic
differences, rather than cell source or methodology, is a major
contributor to variable phenotypes of vMIA-deﬁcient viruses. Overall,
the role of vMIA in modulating mitochondrial activity and oxidative
stress will beneﬁt from further clariﬁcation. The results of the current
study indicate these functions may overlap with pathways inducing
premature cmvPCD. In summary, multiplicity, oxidative stress, and
serine proteases emerge from these studies as determinants of cell
death pathways controlling replication of vMIA-deﬁcient HCMV.Materials and methods
Cells, viruses, and viral yield assays
Human ﬁbroblasts (HFs) and vMIA-HFs were cultured as pre-
viously described (McCormick et al., 2005). The viruses DUL37x1 and
Towne-BAC used in these studies have been characterized previously
(McCormick et al., 2005; McCormick et al., 2008) and were derived
from the BACmid clones Towne-BAC and DUL37x1 (Dunn et al., 2003)
and maintained as DNA clones in E. coli or on complementing vMIA-
HFs prior to experiments. The viruses RVHB5delUL37x1 and RVHB5
were obtained following transfection of BACmid clones RVHB5de-
lUL37x1 and RVHB5 maintained as DNA clones in E. coli or on
complementing vMIA-HFs .
Viral yield and growth following transfection
For growth curves, HFs or vMIA-HFs were infected by DUL37x1
or parental Towne-BAC viruses in triplicate cultures, and yields
were determined from total virus that included cell supernatant
and sonicated infected cells (Sonicator 3000; Misomix, Inc., Farm-
ingdale, NY). Titrations employed 0.16% pooled human gamma
globulin (Baxter Healthcare, Deerﬁeld, IL). Viral growth following
transfection of BACmid DNA was assessed by live cell microscopy
on days 7, 11, and 15.
Live cell imaging and ﬂuorescence analysis of live cultures
Images from live cell cultures were obtained and analyzed as
previously described (McCormick et al., 2005; McCormick et al.,
2008). For purposes of determining ﬂuorescence intensities, live
cultures were analyzed at 371 C with Live Cell Imaging System
IncuCyte FLR (Essen Bioscience, Inc, Ann Arbor, Michigan) with
subsequent data analysis completed in Prism (Graphpad Software,
La Jolla, CA).
Immunoﬂuorescence staining assays
Immunodetection employed mouse monoclonal antibodies to
viral nuclear antigens IE1p72 and IE2p86 (MAB 810, Chemicon,
Temeculah, CA) and Texas Red-conjugated horse anti-mouse IgG
(all from Vector, Burlingame, Calif.).
Impact of protease, kinase, and replication inhibitors on death and
viral yield
Cells grown on coverslips in 24 well dishes or without cover-
slips in 96 well culture dishes were infected then ﬁxed at varying
times with 3.7% formaldehyde or 25% acetic acid in methanol,
then permeabilized with Triton X-100 (EMD Biosciences, Darm-
stadt, Germany), stained with Hoechst 33258 (AnaSpec, San Jose,
CA), and processed for microscopic evaluation as previously
described or alternatively, infected cells were detached from
culture dishes by trypsin and sonicated prior to titration on HFs.
Alternatively, virus in supernatant was titered for someexperiments. Cell numbers were determined directly by counting
numbers of GFPþ cells or fragmented GFPþ cells by ﬂuorescence
microscopy, by counting numbers of Trypan Blue negative cells
using a hemacytometer, following immunodetection, by counting
numbers of viral nuclear antigens IE1p72 and IE2p86, comparing to
untreated controls, or indirectly, by determination of intracellular
ATP levels using the Cell Titer-Glo Luminescent Cell Viability
Assay kit (Promega) according to the manufacturer’s instructions.
IE1p72 and IE2p86 positive cells were identiﬁed from ﬂuorescent
micrographs and counted directly or by CellProﬁler software
(Carpenter et al., 2006). Images were collected as previously
described (McCormick et al., 2005; McCormick et al., 2008).
Inhibitors included TLCK (N-alpha-p-tosyl-L-lysine chloro-
methyl ketone) (Sigma, St. Louis, MO) and PFA (phosphonofor-
mate) (Sigma, St. Louis, Mo) dissolved in water, and zVAD.fmk
(Calbiochem, La Jolla, CA), staurosporine (Alexis Biochemicals, San
Diego, CA), and BHA (butylated hydroxyanisole) (Sigma, St. Louis,
MO) dissolved in DMSO (Sigma, St. Louis, Mo). Inhibitors were
added by replacing culture medium with medium containing
inhibitor while control medium included the appropriate solvent
(DMSO) or no addition. DMSO does not impact death or CMV
replication levels at the concentrations used (r0.1%) (McCormick
et al., 2005). Viral yield was determined from supernatant
combined with sonicated cells as described above.
Statistical analyses
All data reported in text have been collected from experiments
that have been repeated and are graphed as the mean with
standard deviations determined within Microsoft Excel or Prism
Graphpad. For purposes of determining statistical signiﬁcance,
data were analyzed in Prism Graphpad by unpaired t test.Acknowledgments
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